Page last updated: 2024-10-24

chlorambucil and Pre-Eclampsia

chlorambucil has been researched along with Pre-Eclampsia in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, R1
Ozkalemkas, F1
Kimya, Y1
Koksal, N1
Ozkocaman, V1
Yorulmaz, H1
Eroglu, A1
Ozcelik, T1
Tunali, A1

Other Studies

1 other study available for chlorambucil and Pre-Eclampsia

ArticleYear
Pregnancy in chronic lymphocytic leukemia: experience with fetal exposure to chlorambucil.
    Leukemia research, 2009, Volume: 33, Issue:4

    Topics: Adult; Allopurinol; Antimetabolites; Antineoplastic Agents, Alkylating; Chlorambucil; Female; Fetus;

2009